These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 33478499)
1. Direct from the COVID-19 crisis: research and innovation sparks in Brazil. Rosa MFF; da Silva EN; Pacheco C; Diógenes MVP; Millett C; Gadelha CAG; Santos LMP Health Res Policy Syst; 2021 Jan; 19(1):10. PubMed ID: 33478499 [TBL] [Abstract][Full Text] [Related]
2. The health economic-industrial complex: production and innovation for universal health access, Brazil. Gadelha CA; Maretto G; Nascimento MA; Kamia F Bull World Health Organ; 2024 May; 102(5):352-356. PubMed ID: 38680461 [TBL] [Abstract][Full Text] [Related]
3. Conflicts of interest in research involving human beings. Greco D; Diniz NM J Int Bioethique; 2008; 19(1-2):143-54, 202-3. PubMed ID: 18664007 [TBL] [Abstract][Full Text] [Related]
4. The 2023 Latin America report of the Hartinger SM; Palmeiro-Silva YK; Llerena-Cayo C; Blanco-Villafuerte L; Escobar LE; Diaz A; Sarmiento JH; Lescano AG; Melo O; Rojas-Rueda D; Takahashi B; Callaghan M; Chesini F; Dasgupta S; Posse CG; Gouveia N; Martins de Carvalho A; Miranda-Chacón Z; Mohajeri N; Pantoja C; Robinson EJZ; Salas MF; Santiago R; Sauma E; Santos-Vega M; Scamman D; Sergeeva M; Souza de Camargo T; Sorensen C; Umaña JD; Yglesias-González M; Walawender M; Buss D; Romanello M Lancet Reg Health Am; 2024 May; 33():100746. PubMed ID: 38800647 [TBL] [Abstract][Full Text] [Related]
5. A Cross-sectional Survey of Public Knowledge and Perspective on Coronavirus Disease, Vaccination, and Related Research in India during the COVID-19 Pandemic. Munshi R; Maurya M J Assoc Physicians India; 2023 Sep; 71(9):19-27. PubMed ID: 38700297 [TBL] [Abstract][Full Text] [Related]
6. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial. Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771 [TBL] [Abstract][Full Text] [Related]
7. Clinical investigations for SUS, the Brazilian public health system. Paula AP; Giozza SP; Pereira MZ; Boaventura PS; Santos LM; Sachetti CG; Tamayo CO; Kowalski CC; Elias FT; Serruya SJ; Guimarães R Sao Paulo Med J; 2012; 130(3):179-86. PubMed ID: 22790551 [TBL] [Abstract][Full Text] [Related]
8. Scientific research and innovation response to the COVID-19 pandemic in Peru. Moya-Salazar J; Gomez-Saenz L; Cañari B; Contreras-Pulache H F1000Res; 2021; 10():399. PubMed ID: 34868555 [No Abstract] [Full Text] [Related]
9. Early public research funding response to COVID-19 pandemic in Brazil. Campo KN; Rodrigues ICP; Lopes ÉSN; Gabriel LP Rev Soc Bras Med Trop; 2020; 53():e20200522. PubMed ID: 32965457 [TBL] [Abstract][Full Text] [Related]
10. Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study. Florentino PTV; Millington T; Cerqueira-Silva T; Robertson C; de Araújo Oliveira V; Júnior JBS; Alves FJO; Penna GO; Vital Katikireddi S; Boaventura VS; Werneck GL; Pearce N; McCowan C; Sullivan C; Agrawal U; Grange Z; Ritchie LD; Simpson CR; Sheikh A; Barreto ML; Rudan I; Barral-Netto M; Paixão ES Lancet Infect Dis; 2022 Nov; 22(11):1577-1586. PubMed ID: 35952702 [TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
12. For socially engaged science: The dynamics of knowledge production in the Fiocruz graduate program in the framework of the "Brazil Without Extreme Poverty Plan". Feltrin RB; Guilam MCR; Barral-Netto M; Lima NT; Moraes MO PLoS One; 2018; 13(10):e0204232. PubMed ID: 30339664 [TBL] [Abstract][Full Text] [Related]
13. Four years of the COVID-19 pandemic: how does Brazil deal with the impacts? A DOHaD perspective. Aquino AM; Cruz LLD; Gouveia HJCB; da Silva MM; Souza MR; Baqueiro MDN; Ribeiro IT; de Lima EV; Martins PVG; Gonçalves CO; Ceravolo GS; Miranda RA J Dev Orig Health Dis; 2024 Sep; 15():e17. PubMed ID: 39308323 [TBL] [Abstract][Full Text] [Related]
14. Rethinking approaches of science, technology, and innovation in healthcare during the COVID-19 pandemic: the challenge of translating knowledge infrastructures to public needs. da Silva RGL; Chammas R; Novaes HMD Health Res Policy Syst; 2021 Jul; 19(1):104. PubMed ID: 34289860 [TBL] [Abstract][Full Text] [Related]
15. Vaccines in Brazil: historical analysis of the Sanitary registration and vaccine availability in the Brazilian Unified Health System. Peres KC; Buendgens FB; Prates EA; Bonetti NR; Soares L; Vargas-Peláez CM; Farias MR Cien Saude Colet; 2021 Nov; 26(11):5509-5522. PubMed ID: 34852086 [TBL] [Abstract][Full Text] [Related]
16. PNAD COVID-19: A powerful new tool for Public Health Surveillance in Brazil. Penna GO; Silva JAAD; Neto JC; Temporão JG; Pinto LF Cien Saude Colet; 2020 Sep; 25(9):3567-3571. PubMed ID: 32876259 [TBL] [Abstract][Full Text] [Related]
17. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism. Amanpour S Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952 [TBL] [Abstract][Full Text] [Related]
18. Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models. Alonso Ruiz A; Bezruki A; Shinabargar E; Large K; Vieira M; Slovenski I; Liu Y; Agarwal S; Becker A; Moon S Global Health; 2024 Mar; 20(1):25. PubMed ID: 38532484 [TBL] [Abstract][Full Text] [Related]
19. Science funding crisis in Brazil and COVID-19: deleterious impact on scientific output. Oliveira EA; Martelli JÚnior H; Silva ACSE; Martelli DRB; Oliveira MCL An Acad Bras Cienc; 2020; 92(4):e20200700. PubMed ID: 32844986 [TBL] [Abstract][Full Text] [Related]